Palatin Technologies
PTN
#10059
Rank
โ‚น2.56 B
Marketcap
โ‚น1,507
Share price
9.77%
Change (1 day)
1,725.91%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -โ‚น0.4 Billion

According to Palatin Technologies's latest financial reports the company's current earnings are โ‚น8.84 Million. In 2024 the company made an earning of -โ‚น2.41 Billion, an increase over its 2023 earnings that were of -โ‚น2.9 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น0.4 Billion-83.58%
2024 -โ‚น2.41 Billion-16.9%
2023 -โ‚น2.9 Billion5.99%
2022 -โ‚น2.74 Billion-13.7%
2021 -โ‚น3.17 Billion33.25%
2020 -โ‚น2.38 Billion-172.11%
2019 โ‚น3.29 B2352.33%
2018 โ‚น0.13 B-94.13%
2017 โ‚น2.29 B-154.92%
2016 -โ‚น4.18 Billion3.67%
2015 -โ‚น4.03 Billion878%
2014 -โ‚น0.42 Billion-72.64%
2013 -โ‚น1.51 Billion-33.11%
2012 -โ‚น2.25 Billion77.71%
2011 -โ‚น1.27 Billion
2003 -โ‚น2.15 Billion29.93%
2002 -โ‚น1.65 Billion36.18%
2001 -โ‚น1.22 Billion
1999 -โ‚น1.01 Billion6.04%
1998 -โ‚น0.95 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-โ‚น1.08 Billion 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚น2.64 Billion 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น52.13 B-12,262.47%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น4.51 B-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น5.97 B-1,492.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น10.52 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.896 T-675,709.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚น4.97 Billion 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.170 T-273,088.15%๐Ÿ‡ฌ๐Ÿ‡ง UK